Literature DB >> 32139030

Prevention and reduction of involuntary treatment at home: A feasibility study of the PRITAH intervention.

Angela M H J Mengelers1, Michel H C Bleijlevens2, Hilde Verbeek3, Vincent R A Moermans4, Elizabeth Capezuti5, Jan P H Hamers6.   

Abstract

Sometimes care is provided to a cognitively impaired person against the person's will, referred to as involuntary treatment. We developed the PRITAH intervention, aimed at prevention and reduction of involuntary treatment at home. PRITAH consists of a policy discouraging involuntary treatment, workshops, coaching by a specialized nurse and alternative interventions. A feasibility study was conducted including 30 professional caregivers. Feasibility was assessed by attendance lists (reach), a logbook (dose delivered and fidelity), evaluation questionnaires and focus group interviews (dose received, satisfaction & barriers). The workshops and coach were positively evaluated and the average attendance rate was 73%. Participants gained more awareness and knowledge and received practical tips and advice to prevent involuntary treatment. Implementation of the intervention was feasible with minor deviations from protocol. Recommendations for improvement included more emphasis on involvement of family caregivers and general practitioners and development of an extensive guideline to comply with the policy.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Feasibility; Home care; Intervention; Involuntary treatment; Professional caregiver

Mesh:

Year:  2020        PMID: 32139030     DOI: 10.1016/j.gerinurse.2020.02.001

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.361


  1 in total

1.  Autonomy conquers all: a thematic analysis of nurses' professional judgement encountering resistance to care from home-dwelling persons with dementia.

Authors:  Åshild Gjellestad; Trine Oksholm; Herdis Alvsvåg; Frøydis Bruvik
Journal:  BMC Health Serv Res       Date:  2022-06-04       Impact factor: 2.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.